James D. Clark - Feb 21, 2022 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Role
SVP, Cont & Chief Acct Officer
Signature
/s/ James D. Clark
Stock symbol
CVS
Transactions as of
Feb 21, 2022
Transactions value $
$0
Form type
4
Date filed
2/23/2022, 03:23 PM
Previous filing
Feb 1, 2022
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CVS Common Stock Award $0 +8.6K +49.12% $0.00 26.1K Feb 21, 2022 Direct F1
holding CVS Common Stock (restricted) 16.9K Feb 21, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CVS Stock Option 7.04K Feb 21, 2022 Common Stock 7.04K $104.82 Direct F2
holding CVS Stock Option 9.05K Feb 21, 2022 Common Stock 9.05K $78.05 Direct F3
holding CVS Stock Option 7.51K Feb 21, 2022 Common Stock 7.51K $62.21 Direct F4
holding CVS Stock Option 24.2K Feb 21, 2022 Common Stock 24.2K $54.19 Direct F5
holding CVS Stock Option 17.2K Feb 21, 2022 Common Stock 17.2K $58.34 Direct F6, F7
holding CVS Stock Option 12.1K Feb 21, 2022 Common Stock 12.1K $74.30 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022.
F2 Options became exercisable in four equal annual installments beginning on 4/1/2017.
F3 Options became exercisable in four equal annual installments beginning on 4/3/2018.
F4 Options became exercisable in four equal annual installments, commencing 4/1/2019.
F5 Options became exercisable in four equal annual installments, commencing 4/1/2020.
F6 The number of shares subject to the option were calculated using a 30-day average price.
F7 Options became exercisable in four equal annual installments, commencing 4/1/2021.
F8 Option becomes exercisable in four equal annual installments, commencing 4/1/2022.